|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-4-21
|
|
pubmed:abstractText |
Docetaxel and pemetrexed have been validated as therapeutics for previously treated advanced non-small-cell lung cancer (NSCLC), but tolerability is a concern for standard treatment with docetaxel administered once every 3 weeks (tri-weekly 75-mg/m(2) schedule). We conducted this retrospective study to compare the efficacy and toxicity of weekly low-dose docetaxel versus tri-weekly pemetrexed for previously treated advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9794
|
|
pubmed:author |
pubmed-author:ChungFu-TsaiFT,
pubmed-author:FangYueh-FuYF,
pubmed-author:FengPo-HaoPH,
pubmed-author:KuoChih-HsiCH,
pubmed-author:KuoHan-PinHP,
pubmed-author:LeeKang-YunKY,
pubmed-author:LinShu-MinSM,
pubmed-author:LinTing-YuTY,
pubmed-author:LoYun-LunYL,
pubmed-author:NiYung-LunYL,
pubmed-author:ShiehMeng-HengMH,
pubmed-author:YuChih-TengCT
|
|
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-55
|
|
pubmed:meshHeading |
pubmed-meshheading:21454972-Aged,
pubmed-meshheading:21454972-Antineoplastic Agents,
pubmed-meshheading:21454972-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21454972-Disease-Free Survival,
pubmed-meshheading:21454972-Dose-Response Relationship, Drug,
pubmed-meshheading:21454972-Drug Administration Schedule,
pubmed-meshheading:21454972-Female,
pubmed-meshheading:21454972-Glutamates,
pubmed-meshheading:21454972-Guanine,
pubmed-meshheading:21454972-Humans,
pubmed-meshheading:21454972-Lung Neoplasms,
pubmed-meshheading:21454972-Male,
pubmed-meshheading:21454972-Middle Aged,
pubmed-meshheading:21454972-Retrospective Studies,
pubmed-meshheading:21454972-Taxoids,
pubmed-meshheading:21454972-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Low-dose weekly docetaxel is as tolerable as pemetrexed in previously treated advanced non-small-cell lung cancer.
|
|
pubmed:affiliation |
Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taipei, Taiwan, ROC.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
